Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
iTeos Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ITOS
Nasdaq
8731
https://www.iteostherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for iTeos Therapeutics Inc
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
- May 10th, 2024 12:26 pm
iTeos Therapeutics Announces $120 Million Registered Direct Offering
- May 10th, 2024 12:24 pm
iTeos shares jump on TIGIT update; Acelyrin swaps CEOs
- May 10th, 2024 12:09 pm
iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
- Apr 7th, 2024 8:30 pm
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
- Mar 6th, 2024 12:01 pm
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
- Mar 6th, 2024 12:00 pm
iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
- Mar 5th, 2024 9:30 pm
iTeos to Participate in Upcoming Investor Conferences
- Mar 1st, 2024 12:00 pm
Strength Seen in iTeos Therapeutics, Inc. (ITOS): Can Its 7.4% Jump Turn into More Strength?
- Feb 26th, 2024 11:11 am
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
- Jan 8th, 2024 12:00 pm
iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 12:00 pm
Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade
- Dec 13th, 2023 2:55 pm
Does iTeos Therapeutics, Inc. (ITOS) Have the Potential to Rally 283.59% as Wall Street Analysts Expect?
- Nov 27th, 2023 2:55 pm
iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference
- Nov 21st, 2023 12:00 pm
Here's Why iTeos Therapeutics, Inc. (ITOS) Could be Great Choice for a Bottom Fisher
- Nov 13th, 2023 2:55 pm
Wall Street Analysts Predict a 304.26% Upside in iTeos Therapeutics, Inc. (ITOS): Here's What You Should Know
- Nov 10th, 2023 2:55 pm
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
- Nov 7th, 2023 12:00 pm
Viridian Therapeutics, Inc. (VRDN) Stock Jumps 5.2%: Will It Continue to Soar?
- Oct 31st, 2023 7:01 am
iTeos Therapeutics, Inc. (ITOS) Stock Jumps 5.4%: Will It Continue to Soar?
- Oct 16th, 2023 8:38 am
NCR Atleos Set to Join S&P SmallCap 600
- Oct 11th, 2023 9:55 pm
Scroll